Variables | Total | Overall survival | P | |
---|---|---|---|---|
Median ± SE | 95% CI | |||
XIAP | 0.000 | |||
Low | 23 | 44.00 ± 0.99 | 42.05 to 45.95 | |
High | 55 | 20.00 ± 1.30 | 17.45 to 22.55 | |
NF-κB | 0.000 | |||
Low | 20 | 44.00 ± 1.20 | 41.66 to 46.34 | |
High | 58 | 20.00 ± 1.37 | 17.32 to 22.68 | |
Gender | 0.624 | |||
Male | 48 | 22.00 ± 1.79 | 18.48 to 25.52 | |
Female | 30 | 30.00 ± 4.71 | 20.77 to 39.23 | |
Age | 0.956 | |||
< 60 | 48 | 22.00 ± 3.10 | 15.92 to 28.08 | |
≥ 60 | 30 | 26.00 ± 5.11 | 15.98 to 36.02 | |
Tumor location | 0.421 | |||
Lower thoracic | 44 | 22.00 ± 7.37 | 7.56 to 36.44 | |
Middle and Upper thoracic | 34 | 40.13 ± 5.68 | 19.58 to 28.42 | |
Length of tumor | 0.421 | |||
< 5 cm | 44 | 24.00 ± 2.25 | 19.58 to 28.42 | |
≥ 5 cm | 34 | 22.00 ± 7.37 | 7.56 to 36.44 | |
T-stage | 0.202 | |||
T3 | 53 | 24.00 ± 2.59 | 18.93 to 29.07 | |
T1-2 | 25 | 29.00 ± 5.34 | 18.53 to 39.47 | |
N-stage | 0.238 | |||
N0 | 33 | 24.00 ± 7.65 | 9.01 to 38.99 | |
N1 | 45 | 24.00 ± 2.93 | 18.25 to 29.75 | |
p-TNM stage | 0.076 | |||
I-II | 28 | 32.00 ± 2.82 | 26.48 to 37.52 | |
III | 50 | 20.00 ± 2.18 | 15.74 to 24.26 | |
Differentiation | 0.000 | |||
Well and Medium | 51 | 34.00 ± 3.40 | 27.35 to 40.66 | |
Poor | 27 | 16.00 ± 2.43 | 11.24 to 20.76 |